Send to

Choose Destination
See comment in PubMed Commons below
Clin Res Hepatol Gastroenterol. 2012 Jun;36(3):209-13. doi: 10.1016/j.clinre.2011.10.008. Epub 2011 Dec 3.

Squamous-cell carcinoma of the anal canal: room for improvement with targeted therapy.

Author information

  • 1Instituto do Cancer do Estado de São Paulo, 251 avenida Doutor Arnaldo, 01246-000 São Paulo, Brazil.


Carcinoma of the anal canal is a rare disease accounting for 1-5% of gastrointestinal tract malignancies. However, its incidence is increasing worldwide. Chemoradiation is the standard treatment for most patients with squamous-cell carcinoma of the anal canal and was first described by Nigro et al. Since then, no other effective treatment was developed. Patients with metastatic disease should be considered candidates for clinical trials. New treatment strategies, including molecular target therapies, are warranted in order to improve disease control. Despite the rarity of this disease, it is urgent to improve its treatment by introducing targeted therapy in the arena.

Copyright © 2011 Elsevier Masson SAS. All rights reserved.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk